These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 18452597)

  • 1. Cholestatic hepatitis as a possible new side-effect of oxycodone: a case report.
    Ho V; Stewart M; Boyd P
    J Med Case Rep; 2008 May; 2():140. PubMed ID: 18452597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid withdrawal presenting only nausea during tapering of oxycodone after celiac plexus block: a case report.
    Sakamoto A; Takayama H; Mamiya K; Koizumi T
    Ann Palliat Med; 2016 Jan; 5(1):67-70. PubMed ID: 26841817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of fosinopril-induced severe cholestatic jaundice with plasma exchange.
    Chou JW; Yu CJ; Chuang PH; Lai HC; Hsu CH; Cheng KS; Peng CY; Chiang IP
    Ann Pharmacother; 2008 Dec; 42(12):1887-92. PubMed ID: 19017832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combatting pain after orthopedic/trauma surgery- perioperative oral extended-release tapentadol vs. extended-release oxycodone/naloxone.
    Haeseler G; Schaefers D; Prison N; Ahrens J; Liu X; Karch A
    BMC Anesthesiol; 2017 Jul; 17(1):91. PubMed ID: 28693439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hepatic tolerance of atypical antipsychotic drugs].
    Dumortier G; Cabaret W; Stamatiadis L; Saba G; Benadhira R; Rocamora JF; Aubriot-Delmas B; Glikman J; Januel D
    Encephale; 2002; 28(6 Pt 1):542-51. PubMed ID: 12506267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged-Release (PR) Oxycodone/Naloxone Improves Bowel Function Compared with Oxycodone PR and Provides Effective Analgesia in Chinese Patients with Non-malignant Pain: A Randomized, Double-Blind Trial.
    Leng X; Zhang F; Yao S; Weng X; Lu K; Chen G; Huang M; Huang Y; Zeng X; Hopp M; Lu G
    Adv Ther; 2020 Mar; 37(3):1188-1202. PubMed ID: 32020565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydralazine-induced cholestatic hepatitis.
    Hassan A; Hammad R; Cucco R; Niranjan S
    Am J Ther; 2009; 16(4):371-3. PubMed ID: 19092641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nafcillin-Induced Hepatic Injury: A Case Report and Literature Review.
    Khatib S; Sabobeh T; Bock MD; Masoud A; Alallaf J
    Cureus; 2021 Jan; 13(1):e12817. PubMed ID: 33628683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged-release oxycodone/naloxone in nonmalignant pain: single-center study in patients with constipation.
    Gatti A; Casali M; Lazzari M; Tufaro G; Gafforio P; Silvestri C; Marcassa C; Sabato AF
    Adv Ther; 2013 Jan; 30(1):41-59. PubMed ID: 23269562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerability of tapentadol immediate release in patients with lower back pain or osteoarthritis of the hip or knee over 90 days: a randomized, double-blind study.
    Hale M; Upmalis D; Okamoto A; Lange C; Rauschkolb C
    Curr Med Res Opin; 2009 May; 25(5):1095-104. PubMed ID: 19301989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Escitalopram-induced hepatitis: A case report.
    Wabont G; Ferret L; Houdre N; Lepied A; Bene J; Cousein E
    World J Clin Cases; 2022 Mar; 10(8):2468-2473. PubMed ID: 35434055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxytrex minimizes physical dependence while providing effective analgesia: a randomized controlled trial in low back pain.
    Webster LR; Butera PG; Moran LV; Wu N; Burns LH; Friedmann N
    J Pain; 2006 Dec; 7(12):937-46. PubMed ID: 17157780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of oral oxycodone and oxycodone/naloxone combination in opioid-naïve cancer patients: a propensity analysis.
    Lazzari M; Greco MT; Marcassa C; Finocchi S; Caldarulo C; Corli O
    Drug Des Devel Ther; 2015; 9():5863-72. PubMed ID: 26586937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe cholestatic jaundice in hyperthyroidism after treatment with 131-iodine.
    Hasan MK; Tierney WM; Baker MZ
    Am J Med Sci; 2004 Dec; 328(6):348-50. PubMed ID: 15599331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Severe cholestatic hepatitis revealing a DRESS syndrome].
    Droz N; Thiebaut M; Terrier B; Bérézné A; Sogni P; Beuvon F; Guillevin L; Mouthon L
    Rev Med Interne; 2013 Oct; 34(10):645-8. PubMed ID: 23541141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delta-opioid receptor antagonist naltrindole reduces oxycodone addiction and constipation in mice.
    Yang PP; Yeh TK; Loh HH; Law PY; Wang Y; Tao PL
    Eur J Pharmacol; 2019 Jun; 852():265-273. PubMed ID: 30959048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin-induced mixed hepatocellular and cholestatic hepatic injury: case report and literature review.
    Saadi T; Waterman M; Yassin H; Baruch Y
    Int J Gen Med; 2013; 6():703-6. PubMed ID: 23983487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case report of nifedipine-induced hepatitis with jaundice.
    Yusuf D; Christy J; Owen D; Ho M; Li D; Fishman MJ
    BMC Res Notes; 2018 Apr; 11(1):228. PubMed ID: 29615102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analgesic efficacy and safety of oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic pain.
    Vondrackova D; Leyendecker P; Meissner W; Hopp M; Szombati I; Hermanns K; Ruckes C; Weber S; Grothe B; Fleischer W; Reimer K
    J Pain; 2008 Dec; 9(12):1144-54. PubMed ID: 18708300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of controlled-release oxycodone and standard therapies for postoperative pain after knee or hip replacement.
    de Beer Jde V; Winemaker MJ; Donnelly GA; Miceli PC; Reiz JL; Harsanyi Z; Payne LW; Darke AC
    Can J Surg; 2005 Aug; 48(4):277-83. PubMed ID: 16149361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.